治疗性寡核酸的下一代纳米载体:精确准和刺激响应性癌症治疗
Yantong Li1, Mei Zhang1, Junjie Gu1
1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, PR China.
Pharmacology & therapeutics
|November 20, 2025
概括
治疗性寡核酸 (TOs) 在癌症基因治疗方面表现有前途. 智能纳米载体改善TO传递,克服诸如弱准和稳定性等挑战,用于增强瘤治疗.
科学领域:
- 生物医学工程 生物医学工程
- 基因治疗 基因治疗
- 纳米技术纳米技术
背景情况:
- 治疗性寡核酸 (TOs) 为癌症治疗提供有针对性的基因调制.
- 对TOs的临床应用受到传递挑战的限制,例如稳定性差,准和溶酶体捕获.
- 先进的交付系统对于克服这些局限性至关重要.
研究的目的:
- 审查智能纳米粒子在癌症治疗中用于治疗性寡核酸输送的进展.
- 讨论增强瘤特异向和TOs刺激响应释放的策略.
- 为设计下一代纳米材料提供洞察力,以改善基于TO的瘤治疗.
主要方法:
- 对用于TO传递的纳米载体系统的当前文献进行全面审查.
- 对TO分类,治疗机制和纳米载体类别的分析.
- 讨论TO纳米材料的结合模式和准策略.
主要成果:
- 智能纳米载体提高了TOs的安全性,稳定性和准效率.
- 纳米粒子集成可以实现受控释放,克服生物障碍.
- 针对瘤特异性向和刺激响应性传递的策略是关键.
结论:
- 智能纳米载体代表了使用TOs精确的癌症基因治疗的非常有前途的战略.
- 解决纳米载体系统的设计考虑对于提高TO效率至关重要.
- 这些系统的进一步开发将推动基于TO的瘤治疗.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K